Opus Genetics Quote - IRD

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.11

Bid

1.10

Offer

1.11

Volume

139,745

1.102 Day's Range 1.20

0.81 52 Week Range 1.56

Market Cap

35.041M

Previous Close

1.17

Open

1.17

Last Trade

1.11

Last Trade Time

03:19:26

Financial Volume

US$ 160,758

VWAP

1.1504

Average Volume (3m)

237,151

Shares Outstanding

31,568,457

Dividend Yield

PE Ratio

-5.72

Earnings Per Share (EPS)

-0.32

Revenue

19.05M

Net Profit

-9.99M

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol ... Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema. Show more

Sector

Motion Pic, Videotape Prodtn

Industry

Pharmaceutical Preparations

Website

www.ocuphire.com

Headquarters

Wilmington, Delaware, USA

Founded

1999

Opus Genetics Inc is listed in the Motion Pic, Videotape Prodtn sector of the NASDAQ with ticker IRD. The last closing price for Opus Genetics was US$1.17. Over the last year, Opus Genetics shares have traded in a share price range of US$ 0.81 to US$ 1.56.

Opus Genetics currently has 31,568,457 shares in issue. The market capitalisation of Opus Genetics is US$36.94 million. Opus Genetics has a price to earnings ratio (PE ratio) of -5.72.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.01	-0.892857142857	1.12	1.22	1.07	127903	1.13845596	CS
4	-0.07	-5.93220338983	1.18	1.56	1.07	197750	1.27992158	CS
12	-0.06	-5.12820512821	1.17	1.56	0.81	237151	1.101054	CS
26	-0.08	-6.72268907563	1.19	1.56	0.81	224997	1.1109472	CS
52	-0.08	-6.72268907563	1.19	1.56	0.81	224997	1.1109472	CS
156	-0.08	-6.72268907563	1.19	1.56	0.81	224997	1.1109472	CS
260	-0.08	-6.72268907563	1.19	1.56	0.81	224997	1.1109472	CS

IRD - Frequently Asked Questions (FAQ)

What is the current Opus Genetics share price?

The current share price of Opus Genetics is US$ 1.11

How many Opus Genetics shares are in issue?

Opus Genetics has 31,568,457 shares in issue

What is the market cap of Opus Genetics?

The market capitalisation of Opus Genetics is USD 36.94M

What is the 1 year trading range for Opus Genetics share price?

Opus Genetics has traded in the range of US$ 0.81 to US$ 1.56 during the past year

What is the PE ratio of Opus Genetics?

The price to earnings ratio of Opus Genetics is -5.72

What is the cash to sales ratio of Opus Genetics?

The cash to sales ratio of Opus Genetics is 3

What is the reporting currency for Opus Genetics?

Opus Genetics reports financial results in USD

What is the latest annual turnover for Opus Genetics?

The latest annual turnover of Opus Genetics is USD 19.05M

What is the latest annual profit for Opus Genetics?

The latest annual profit of Opus Genetics is USD -9.99M

What is the registered address of Opus Genetics?

The registered address for Opus Genetics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808

What is the Opus Genetics website address?

The website address for Opus Genetics is www.ocuphire.com

Which industry sector does Opus Genetics operate in?

Opus Genetics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SLXNSilexion Therapeutics Corporation	US$ 1.22 (110.34%)	167M
YIBOPlanet Image International Ltd	US$ 5.095 (65.42%)	46.95M
RNAZTransCode Therapeutics Inc	US$ 10.87 (59.15%)	14.04M
BACKIMAC Holdings Inc	US$ 1.1708 (41.23%)	51.99M
TRIBTrinity Biotech PLC	US$ 1.06 (39.47%)	97.64M
LPTXLeap Therapeutics Inc	US$ 0.6652 (-70.44%)	7.28M
STSSSharps Technology Inc	US$ 0.45555 (-68.80%)	10.92M
SABSSAB Biotherapeutics Inc	US$ 2.156 (-50.55%)	872.97k
MGOLMGO Global Inc	US$ 0.1791 (-36.71%)	13.51M
INKTMiNK Therapeutics Inc	US$ 6.60 (-25.33%)	28.8k
HEPAHepion Pharmaceuticals Inc	US$ 0.2138 (29.58%)	224.97M
NVDANVIDIA Corporation	US$ 120.6001 (1.84%)	217.94M
SLXNSilexion Therapeutics Corporation	US$ 1.2103 (108.67%)	167.08M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.503 (22.06%)	101.07M
TRIBTrinity Biotech PLC	US$ 1.0699 (40.78%)	97.64M